• Profile
Close

Prospective, observational, non-interventional, multicentre study on the efficacy and tolerability of a new calcipotriol/betamethasone aerosol foam (Enstilar) in patients with plaque psoriasis under daily practice conditions

Dermatology Mar 07, 2018

Gerdes S, et al. - The effectiveness and tolerability of the new aerosol foam of calcipotriol 50 µg/g plus betamethasone dipropionate 0.5 mg/g was evaluated (Cal/BD foam, Enstilar) in psoriasis vulgaris under daily practice conditions. Findings demonstrated convincing efficacy and tolerability profile of the new Cal/BD foam in daily practice, specifically in cases with severer disease manifestations.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay